South Africa plans to share the 1 million AstraZeneca Covid-19 vaccine doses it received from the Serum Institute of India with other African countries via the African Union (AU), a senior health official said on Tuesday. The country paused the rollout of the AstraZeneca vaccine this month, after preliminary trial data showed it offered minimal protection against mild to moderate illness from the country’s dominant coronavirus variant. Subscribe for full access to all our share and unit trust data tools, our award-winning articles, and support quality journalism in the process. You will be redirected to a checkout page.
To view all features and options, click here. A monthly subscription is charged pro rata, based on the day of purchase. This is non-refundable and includes a R5 once-off sign-up fee.
A yearly subscription is refundable within 14 days of purchase and includes a 365-day membership. It plans to start inoculating healthcare workers with Johnson & Johnson’s vaccine as soon as this week in a research study. “The doses are going to be shared with countries on the continent … via the AU,” Anban Pillay, deputy director-general at the Department of Health, told Reuters. He added that South Africa would look to recover money spent on the vaccine doses but was still finalising how to do that. Pillay said a report in Indian newspaper The Economic Times that South Africa had asked the Serum Institute to take back the 1 million doses that arrived at the start of the month was not true.